News Press Releases

LED Medical Diagnostics VELscope(R) Vx Receives 2017 Cellerant Best of Class Technology Award for Seventh Consecutive Year

V.LME | November 7, 2017

LED Medical Diagnostics’ VELscope® Vx Receives 2017 Cellerant “Best of Class” Technology Award for Seventh Consecutive Year

Vancouver, British Columbia (FSCwire) - LED Medical Diagnostics Inc. ("LED Medical" or "the Company"), has proudly announced that its VELscope® Vx Enhanced Oral Assessment System with iPod* touch integration, manufactured by its subsidiary LED Dental Inc. (“LED Dental”), has received the Cellerant “Best of Class” Technology Award. The VELscope Vx has once again been designated as the leading device for the “oral screening” category, receiving the award for a record seventh consecutive year.

The VELscope Vx utilizes tissue fluorescence technology that is used as an adjunct to the traditional comprehensive oral examination, aiding in the enhanced visualization of a variety of oral mucosal abnormalities, including oral cancer and pre-malignant dysplasia. By incorporating the VELscope Vx into their standard oral health screening protocol, clinicians can have an additional tool to help ensure that areas of concern are detected, even those that may not be apparent or even visible with the naked eye.

“LED Dental is proud to be awarded the ‘Best of Class’ in oral screening devices,” stated Wayne Rees, vice president of imaging for LED Dental. “Our goal is to provide practices with the best technologies to care for their patients and this recognition from industry experts further solidifies VELscope’s placement at the forefront of adjunctive screening technology.”

Now in its ninth year, The Cellerant “Best of Class” Technology Award is one of the most prestigious dental industry honors recognizing innovation from manufacturers and service providers. “Best of Class” honorees are chosen by a panel of leading voices in dental technology that comes together each year to discuss, debate and decide which products merit recognition.

“Selection as a ‘Best of Class’ winner acknowledges companies that are creating innovative dental technologies that will help shape the future of our profession,” said Dr. Lou Shuman, Best of Class Founder and Cellerant CEO.

In addition to Dr. Shuman, the 2017 “Best of Class” panel consisted of Dr. John Flucke, Technology Editor for Dental Products Report; Paul Feuerstein, DMD, Technology Editor for Dentistry Today; Marty Jablow, DMD, known as America’s Technology Coach; and Parag Kachalia, DDS, Vice-Chair of Preclinical Education, Research and Technology, University of Pacific School of Dentistry.

“We research the best available technologies for an entire year leading up to the announcement of award winners,” said Dr. Marty Jablow. “To be selected as ‘Best of Class’ after all of that scrutiny and deliberation means that our panel is confident in recommending winning technologies to our peers”.

“We are grateful that the VELscope has once again been recognized for a record seventh consecutive year by such a prestigious panel of technology experts,” stated Dr. David Gane, CEO of LED Medical Diagnostics. “It is quite an honor to receive an award that is a collaborative decision by many of the top thought leaders in dental technology today.”

For more information on the VELscope Vx, please visit www.velscope.com.

About LED Medical Diagnostics Inc.

LED Medical Diagnostics Inc. is a dental imaging technology provider focused on delivering state-of-the-art imaging software and systems. Through its wholly-owned subsidiaries LED Dental Inc., LED Dental Ltd., and Apteryx, Inc., LED Medical has provided dentists and oral health specialists with advanced diagnostic imaging products and software for over 20 years. LED’s proprietary technologies include the VELscope Vx Enhanced Oral Assessment and TUXEDO Intraoral Sensors, in addition to Apteryx’s XrayVision, XVWeb and XrayVision DCV imaging software solutions.

Backed by an experienced leadership team and dedicated to a higher level of service and support, LED is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio. The Company is currently listed on the TSX-V under the symbol LMD, the OTCQB under the symbol LEDIF, as well as the Frankfurt Stock Exchange under the symbol LME.

About Cellerant Consulting Group

The “Best of Class” Technology awards were launched in 2009 as a new concept to provide an unbiased, non-profit assessment of available technologies in the dental space. Through print and digital media coverage, the “Best of Class” message reaches the community of 150,000 dentists through multiple touch points—in print and online—educating them about the products. Honoree participation in the “Tech Expo” at the American Dental Association’s Annual Meeting offers face-to-face interaction with the companies as well as technology-centered education provided by members of the panel. Courses at last year’s 2016 meeting sold out. This year’s event was held Oct. 19-23 in Atlanta, GA.

LED Medical Diagnostics

Investor Relations:

Bristol Capital

Glen Akselrod

Phone: 905.326.1888, ext. 10

Email: glen@bristolir.com

Media Contact:

LED Dental

Chris Koch

Phone: 678.293.9413

Email: chris.koch@leddental.com

Corporate Contact:

LED Medical

David Gane, CEO

Phone: 604.434.4614, ext. 227

Email: david.gane@leddental.com

*Apple and iPod touch are trademarks of Apple Inc.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2016. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/LED11072017.pdf
Source: LED Medical Diagnostics Inc. (TSX Venture:LMD, OTCQB:LEDIF, FWB:LME)

To follow LED Medical Diagnostics Inc. on your favorite social media platform or financial websites, please click on the icons below.